Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

DAPA Trial

140 views

Published on

La Dra. Begoña Benito Villabriga analiza los resultados del estudio publicado en ESC Congress 2019.

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

DAPA Trial

  1. 1. Begoña Benito VillabrigaDAPA TrialDAPA Trial
  2. 2. Begoña Benito VillabrigaDAPA Trial Background MADIT II IRIS
  3. 3. Begoña Benito VillabrigaDAPA Trial Background
  4. 4. Begoña Benito VillabrigaDAPA Trial Background
  5. 5. Begoña Benito VillabrigaDAPA Trial Objective
  6. 6. Begoña Benito VillabrigaDAPA Trial Study design Inclusion criteria:
  7. 7. Begoña Benito VillabrigaDAPA Trial Results
  8. 8. Begoña Benito VillabrigaDAPA Trial Results: patient characteristics
  9. 9. Begoña Benito VillabrigaDAPA Trial Results: ICD implant and study groups  Cross-over
  10. 10. Begoña Benito VillabrigaDAPA Trial Results: primary end-point
  11. 11. Begoña Benito VillabrigaDAPA Trial Results: secondary end-points
  12. 12. Begoña Benito VillabrigaDAPA Trial Results
  13. 13. Begoña Benito VillabrigaDAPA Trial Limitations  Premature termination in 2013 (38% of patients), underpowered to answer the hypotheses: interpretation of results?  First inclusion in 2004: dramatic improvement in MI and HF management
  14. 14. Begoña Benito VillabrigaDAPA Trial Conclusions

×